Bridging interval | P-value | |||||||
---|---|---|---|---|---|---|---|---|
Total n (%) | Group 1 ≤2 weeks n (%) | Group 2 2–3 weeks n (%) | Group 3 >3 weeks n (%) | Overall | ≤2 weeks vs. 2–3 weeks | 2–3 weeks vs. >3 weeks | ≤2 weeks vs. >3 weeks | |
Number of patients | 148 | 47 | 43 | 58 | ||||
Follow-up, median months (IQR months) | 41.0 (23.0–59.0) | 45.0 (27.0–60.0) | 45.0 (31.0–59.0) | 31.5 (15.5–59.0) | 0.135 | 0.960 | 0.082 | 0.100 |
Duration of stoma, median days (IQR days) (n=16) | 187.5 (114.5–260.0) | 191.0 (142.3–267.5) | 20.0 (20.0–20.0) | 210.0 (18.5–487.0) | 0.295 | 0.182 | 0.667 | 0.768 |
Permanent stoma at time of last follow–up | 5 (3.4) | 2 (4.3) | 0 (0.0) | 3 (5.2) | 0.385 | 0.495 | 0.259 | 1.000 |
Recurrence | 38 (25.7) | 12 (25.5) | 15 (34.9) | 11 (19.0) | 0.192 | 0.365 | 0.106 | 0.481 |
Death | 47 (31.8) | 17 (36.2) | 12 (27.9) | 18 (31.0) | 0.716 | 0.500 | 0.827 | 0.678 |
Disease-free survival, median months (IQR days) | 38.0 (13.0–59.0) | 45.0 (11.0–60.0) | 39.0 (12.0–58.0) | 31.5 (13.0–57.5) | 0.398 | 0.488 | 0.611 | 0.167 |
3-year disease free survival (%) | 73.5 | 75.3 | 65.7 | 78.2 | 0.281 | 0.321 | 0.121 | 0.608 |
Overall survival, median months (IQR days) | 42.0 (25.0–71.5) | 43.0 (23.0–70.0) | 42.0 (25.0–62.0) | 40.5 (25.5–75.3) | 0.962 | 0.811 | 0.966 | 0.816 |
3-year overall survival (%) | 79.4 | 82.1 | 77.3 | 79.0 | 0.718 | 0.474 | 0.667 | 0.623 |